Plain-English translation of NCT04416724 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This Canadian trial is testing whether a laser procedure called Selective Laser Trabeculoplasty (SLT) works as well as cataract surgery (phacoemulsification) as the first treatment for pseudoexfoliation glaucoma. Both treatments aim to lower the pressure inside your eye, but the study will compare which one helps more patients avoid needing eye drops or additional medications over two years.
Pseudoexfoliation glaucoma is a serious eye condition that requires treatment to prevent vision loss, but doctors are uncertain which approach works better as a starting point. This study will help guide which treatment is most effective for newly diagnosed patients.
You likely qualify if…
You likely don't qualify if…
If you join, you will be randomly assigned to receive either laser treatment or cataract surgery as your initial treatment. You will then be followed for 2 years with regular eye exams to check your eye pressure and see how well the treatment is working. If your eye pressure doesn't reach the target goal, you may be prescribed eye drops. The study team will also review your medical records at 5 and 10 years after your initial treatment to see how you're doing long-term.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Canada